Table II.
Number and percentage of patients with a complete response, by study cycle and overall.
| Day(s)/interval, h | Cycle 1 (N = 88) |
Cycle 2 (N = 82) |
Cycle 3 (N = 78) |
Cycle 4 (N = 69) |
Total (N = 317) |
|||||
|---|---|---|---|---|---|---|---|---|---|---|
| n | (%) | n | (%) | n | (%) | n | (%) | n | (%) | |
| Overall, 0–120 | 60 | (68.2) | 66 | (80.5) | 61 | (78.2) | 56 | (81.2) | 243 | (76.7) |
| Delayed phase, > 24–120 | 73 | (83.0) | 77 | (93.9) | 72 | (92.3) | 65 | (94.2) | 287 | (90.5) |
| Day 1, 0–24 | 68 | (77.3) | 69 | (84.1) | 64 | (82.1) | 58 | (84.1) | 259 | (81.7) |
| Day 2, > 24–48 | 77 | (87.5) | 79 | (96.3) | 75 | (96.2) | 67 | (97.1) | 298 | (94.0) |
| Day 3, > 48–72 | 80 | (90.9) | 80 | (97.6) | 76 | (97.4) | 66 | (95.7) | 302 | (95.3) |
| Day 4, > 72–96 | 84 | (95.5) | 80 | (97.6) | 76 | (97.4) | 67 | (97.1) | 307 | (96.8) |
| Day 5, > 96–120 | 82 | (93.2) | 78 | (95.1) | 74 | (94.9) | 67 | (97.1) | 301 | (95.0) |